Fielder Capital Group LLC purchased a new stake in Centene Corporation (NYSE:CNC – Free Report) in the second quarter, HoldingsChannel.com reports. The fund purchased 7,648 shares of the company’s stock, valued at approximately $491,000.
A number of other institutional investors and hedge funds also recently made changes to their positions in CNC. Baird Financial Group Inc. acquired a new position in Centene during the first quarter valued at approximately $236,000. Sivia Capital Partners LLC boosted its holdings in shares of Centene by 80.0% in the 2nd quarter. Sivia Capital Partners LLC now owns 9,710 shares of the company’s stock valued at $527,000 after purchasing an additional 4,315 shares in the last quarter. CW Advisors LLC increased its stake in shares of Centene by 20.3% in the 2nd quarter. CW Advisors LLC now owns 4,863 shares of the company’s stock valued at $264,000 after purchasing an additional 820 shares during the last quarter. NewEdge Advisors LLC raised its holdings in shares of Centene by 6.1% during the 2nd quarter. NewEdge Advisors LLC now owns 44,945 shares of the company’s stock worth $2,440,000 after buying an additional 2,582 shares in the last quarter. Finally, Treasurer of the State of North Carolina lifted its position in shares of Centene by 0.4% during the 2nd quarter. Treasurer of the State of North Carolina now owns 231,938 shares of the company’s stock worth $12,590,000 after buying an additional 967 shares during the last quarter. Institutional investors own 93.63% of the company’s stock.
Analyst Ratings Changes
A number of research analysts have issued reports on CNC shares. Mizuho set a $63.00 target price on Centene and gave the company a “neutral” rating in a research report on Monday, June 8th. Stifel Nicolaus set a $79.00 price target on shares of Centene in a research note on Monday, August 3rd. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $79.00 price target (up from $68.00) on shares of Centene in a report on Monday, August 3rd. JPMorgan Chase & Co. upped their price objective on shares of Centene from $60.00 to $67.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 4th. Finally, Jefferies Financial Group raised their target price on shares of Centene from $39.00 to $48.00 and gave the company a “hold” rating in a research report on Wednesday, April 29th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, Centene has a consensus rating of “Hold” and a consensus price target of $69.15.
Centene Trading Up 0.1%
NYSE CNC opened at $67.53 on Monday. The stock has a market capitalization of $33.36 billion, a P/E ratio of -6.47, a P/E/G ratio of 0.36 and a beta of 1.08. The business has a 50 day simple moving average of $65.00 and a 200 day simple moving average of $51.69. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.15 and a quick ratio of 1.15. Centene Corporation has a one year low of $27.76 and a one year high of $69.36.
Centene (NYSE:CNC – Get Free Report) last announced its quarterly earnings data on Tuesday, July 28th. The company reported $2.51 EPS for the quarter, topping the consensus estimate of $1.09 by $1.42. The company had revenue of $53.58 billion during the quarter, compared to the consensus estimate of $47.64 billion. Centene had a negative net margin of 2.51% and a positive return on equity of 12.12%. The company’s quarterly revenue was up 9.9% on a year-over-year basis. During the same quarter last year, the firm posted ($0.16) EPS. Centene has set its FY 2026 guidance at 4.800- EPS. Research analysts expect that Centene Corporation will post 4.89 earnings per share for the current year.
Centene Company Profile
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Featured Stories
- Five stocks we like better than Centene
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
